Expert Opinion on Fixed Dose Combination of Dapagliflozin Plus Sitagliptin for Unmet Cardiovascular Benefits in Type 2 Diabetes Mellitus

Expert Opinion on Fixed Dose Combination of Dapagliflozin Plus Sitagliptin for Unmet Cardiovascular Benefits in Type 2 Diabetes Mellitus

Abstract Type 2 diabetes mellitus (T2DM) is known to be associated with macrovascular (coronary heart disease, stroke, and peripheral arterial disease) and microvascular complications (diabetic kidney disease, retinopathy, and peripheral neuropathy). The coexistence of T2DM with established/risk of...

Full description

Saved in:
Bibliographic Details
Main Authors: Soumitra Ray, J Ezhilan, Rajiv Karnik, Ashish Prasad, Rajashree Dhar
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2024-04-01
Series:Journal of Diabetology
Subjects:
complications
diabetes
dpp-4 inhibitors
sglt2 inhibitors
type 2 diabetes
Online Access:https://doi.org/10.4103/jod.jod_19_24
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items